Phase 1b/2a Study to Evaluate Safety and Efficacy of KPG-818 in SLE

Completed · Phase 1/Phase 2 · Has a placebo group

Conditions studied: SLE; Drug

In brief

Study Title A phase 1b/2a multicenter, randomized, double-blind, placebo-controlled study to assess the safety and tolerability, pharmacokinetics and preliminary efficacy of KPG-818 in patients with mild to moderate systemic lupus erythematosus

Key facts

Study ID: NCT04643067
Run by: Kangpu Biopharmaceuticals, Ltd.
People needed: 64
Starts: 2021-06-03
Expected to finish: 2023-08-18
Last updated by the study team: 2024-05-23

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Anniston Medical Clinic — Anniston, Alabama, United States
University of Alabama - Birmingham — Birmingham, Alabama, United States
Clinical Research of West Florida, Inc. — Clearwater, Florida, United States
Hope Clinical Trials, Inc. — Coral Gables, Florida, United States
JY Research Institute Inc — Cutler Bay, Florida, United States
OSIS Clinical Research — Hollywood, Florida, United States
SouthCoast Research Center Inc — Miami, Florida, United States
D & H National Research Centers — Miami, Florida, United States
Charisma Medical and Research Center — Miami Lakes, Florida, United States
San Marcus Research Clinic — Miami Lakes, Florida, United States
Omega Research MetroWest LLC — Orlando, Florida, United States
Clinical Research of West Florida — Tampa, Florida, United States
Oracle Clinical Research — College Park, Georgia, United States
STAT Research — Vandalia, Ohio, United States
Shelby Research LLC — Memphis, Tennessee, United States
Accurate Clinical Management — Houston, Texas, United States
Accurate Clinical Research LLC — Houston, Texas, United States
Sun Research Institute — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.